Resound Vivia 9 60S microRIE vs Vivtone Xpure Hearing Aid

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.

The Vivtone Xpure is a mid-priced behind-the-ear OTC hearing aid priced at $549 that earns a B grade with a SoundScore of 3.1/5 in our lab testing. Ranking #57 of 65 OTC hearing aids tested, this 2023 release offers a mixed performance profile with one notable strength. The Xpure's standout feature is its music streaming quality, scoring an excellent 4.4/5—a full 2.48 points above the OTC category average. For users who prioritize listening to music or audio content through their hearing aids, this represents genuinely strong performance. Speech clarity in quiet environments scores 2.9/5, slightly above the category average but mixed in absolute terms. However, the Xpure shows limitations in several key areas. Speech understanding in noisy environments scores just 1.2/5, falling 0.29 points below the category average. Own-voice comfort is notably low at 0.8/5, sitting 1.71 points below average—users may find their own voice sounds unnatural or boomy. Feedback handling scores a solid 3.3/5 in absolute terms, though this still falls 1.24 points below the strong OTC category average of 4.54/5. The Xpure improves with professional fitting, with the normalized score increasing from 3.0/5 initially to 3.5/5 when tuned. Buyers seeking similar sound quality at lower prices may want to consider alternatives like the Linner Nova Earbud or Nuheara IQBuds Max, both of which scored higher in our testing at lower price points. The Xpure is best suited for users who prioritize excellent music streaming and can accept trade-offs in speech-in-noise performance and own-voice comfort.